Loading...

Loading...

Novo Nordisk Resolves US Wegovy, Ozempic Shortage
By Sofía Garduño - Mon, 02/24/2025 - 11:27
The FDA confirms that US supply of Wegovy and Ozempic now meets or exceeds demand, following Novo Nordisk's US$6.5 billion investment.
https://mexicobusiness.news/tag/ozempic
More Health
GLP-1 Coverage Becomes Key in Job Retention in the US
By Sofía Garduño - Tue, 02/18/2025 - 13:42
A new survey shows GLP-1 medication access is increasingly important for job retention and hiring, with demand driving employer-sponsored coverage.
Global Surge in Counterfeit Ozempic Raises Health Alarms
By Anmol Motwani - Tue, 09/10/2024 - 10:45
Counterfeit Ozempic is spreading globally, causing hospitalizations and deaths. WHO and Interpol warn of severe risks linked to fake batch numbers.
Study Links Ozempic to Fewer Tobacco-Related Healthcare Visits
By MBN Staff - Wed, 07/31/2024 - 07:03
Ozempic users had fewer tobacco-related healthcare visits and smoking cessation aids, suggesting semaglutide might lower smoking desire.

Most Patients Abandon Wegovy, Ozempic Within Two Years: Study
By MBN Staff - Thu, 07/11/2024 - 09:35
Only 25% of patients continue using Wegovy or Ozempic after two years, raising concerns about the cost-effectiveness of these expensive drugs.

Novo Nordisk's Wegvoy Linked to Higher NAION Risk
By Anmol Motwani - Wed, 07/10/2024 - 09:51
Novo Nordisk’s semaglutide in Wegovy and Ozempic shows higher NAION risk. Prices are notably lower in Mexico compared to the US.
Novo Nordisk Invests US$4.1B in NC Facility for Wegovy
By MBN Staff - Wed, 06/26/2024 - 12:02
Novo Nordisk's US$4.1 billion investment in North Carolina will expand production of Wegovy and Ozempic, creating 1,000+ jobs.
HPV, Kidney Function Innovations: The Week in Health
By Sofía Garduño - Thu, 05/30/2024 - 10:00
This week, BD received FDA approval for self-collected vaginal samples for HPV testing, while clinical data showed that Ozempic slows kidney decline.
Ozempic Reduces Kidney Decline in Type 2 Diabetes Patients
By Anmol Motwani - Wed, 05/29/2024 - 11:56
Semaglutide improves kidney function and reduces cardiovascular risks in Type 2 diabetes, a critical issue in global healthcare.
Diabetes and Weight-Loss Drugs May Boost Hip Replacement Recovery
By MBN Staff - Tue, 02/13/2024 - 13:34
Findings suggest diabetes and weight-loss drugs may aid hip replacement patients, but cautious experts call for further research.